Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
João Mauricio Castaldelli-Maia, Victoria Camargos de Oliveira, Flávia Mariana Irber, Israel K. Blaas, Bernard Angerville, Anderson Sousa Martins-da-Silva, Gislaine Koch Gimenes, Marcela Waisman Campos, Julio Torales, Antonio Ventriglio, Carine Guillois, Houria El Ouazzani, Léna Gazaix, Pascal Favré, Alain Dervaux & Gisèle Apter. (2023) Psychopharmacology of smoking cessation medications: focus on patients with mental health disorders. International Review of Psychiatry 0:0, pages 1-21.
Read now
Read now
Benchalak Maneeton, Narong Maneeton, Surinporn Likhitsathian, Pakapan Woottiluk, Punjaree Wiriyacosol, Vudhichai Boonyanaruthee & Manit Srisurapanont. (2018) Escitalopram vs duloxetine in acute treatment of major depressive disorder: meta-analysis and systematic review. Neuropsychiatric Disease and Treatment 14, pages 1953-1961.
Read now
Read now
Rosa A. S. Couto, Luís Moreira Gonçalves, Félix Carvalho, José A. Rodrigues, Cecília M. P. Rodrigues & M. Beatriz Quinaz. (2018) The Analytical Challenge in the Determination of Cathinones, Key-Players in the Worldwide Phenomenon of Novel Psychoactive Substances. Critical Reviews in Analytical Chemistry 48:5, pages 372-390.
Read now
Read now
Michael Thase, Yuko Asami, Dalia Wajsbrot, Kathleen Dorries, Matthieu Boucher & Elizabeth Pappadopulos. (2017) A meta-analysis of the efficacy of venlafaxine extended release 75–225 mg/day for the treatment of major depressive disorder. Current Medical Research and Opinion 33:2, pages 317-326.
Read now
Read now
Mélanie Brignone, Françoise Diamand, Caroline Painchault & Shweta Takyar. (2016) Efficacy and tolerability of switching therapy to vortioxetine versus other antidepressants in patients with major depressive disorder. Current Medical Research and Opinion 32:2, pages 351-366.
Read now
Read now
Narong Maneeton, Benchalak Maneeton, Pakapan Woottiluk, Sirijit Suttajit, Surinporn Likhitsathian, Chawanun Charnsil & Manit Srisurapanont. (2015) Comparative efficacy, acceptability, and tolerability of dexmethylphenidate versus placebo in child and adolescent ADHD: a meta-analysis of randomized controlled trials. Neuropsychiatric Disease and Treatment 11, pages 2943-2952.
Read now
Read now
Articles from other publishers (9)
Qiuju Peng, Lei Shi, Yanying Kong, Yuan Yan, Jielin Zhan, Yuguan Wen, Wenyi Liu, Dexian Yu, Zhijian Zhou & Huacheng Yan. (2020) CX3CL1 rs170364 gene polymorphism has a protective effect against major depression by enhancing its transcriptional activity. Brain Research 1738, pages 146801.
Crossref
Crossref
Martin A Katzman, Xuemei Wang, Dalia B Wajsbrot & Matthieu Boucher. (2020) Effects of desvenlafaxine versus placebo on MDD symptom clusters: A pooled analysis. Journal of Psychopharmacology 34:3, pages 280-292.
Crossref
Crossref
Michele Protti. 2019. Critical Issues in Alcohol and Drugs of Abuse Testing. Critical Issues in Alcohol and Drugs of Abuse Testing
259
271
.
Kiley Cappetta, Chad Beyer, Jessica A. Johnson & Michael H. Bloch. (2018) Meta-analysis: Risk of dry mouth with second generation antidepressants. Progress in Neuro-Psychopharmacology and Biological Psychiatry 84, pages 282-293.
Crossref
Crossref
Marc Grifell, Mireia Ventura, Xoán Carbón, Pol Quintana, Liliana Galindo, Álvaro Palma, Ivan Fornis, Cristina Gil, Magi Farre & Marta Torrens. (2017) Patterns of use and toxicity of new para-halogenated substituted cathinones: 4-CMC (clephedrone), 4-CEC (4-chloroethcatinone) and 4-BMC (brephedrone). Human Psychopharmacology: Clinical and Experimental 32:3, pages e2621.
Crossref
Crossref
Vladimir Maletic, Anna Eramo, Keva Gwin, Steve J. Offord & Ruth A. Duffy. (2017) The Role of Norepinephrine and Its α-Adrenergic Receptors in the Pathophysiology and Treatment of Major Depressive Disorder and Schizophrenia: A Systematic Review. Frontiers in Psychiatry 8.
Crossref
Crossref
Scott T. Barrett, Trevor N. Geary, Amy N. Steiner & Rick A. Bevins. (2016) Sex differences and the role of dopamine receptors in the reward-enhancing effects of nicotine and bupropion. Psychopharmacology 234:2, pages 187-198.
Crossref
Crossref
Hans-Peter Volz, Siegfried Kasper & Hans-Jürgen Möller. 2017. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
795
842
.
H.-P. Volz, S. Kasper & H.-J. Möller. 2016. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
1
48
.